Sally leads the unified Commercial, Sales, and Marketing functions at Ergomed Group.
With an extensive background in regulatory affairs, clinical delivery, and client engagement, Sally has held senior leadership roles at PrimeVigilance, Ergomed CRO, Worldwide Clinical, PPD, Syneos, and at biopharma leaders such as Biogen, Pfizer, and GSK. She brings deep expertise in pharmacovigilance and CRO operations, along with a strong track record of driving sales and accelerating market growth.
Sally is a staunch advocate of transparency, quality and continuous improvement.
Sally holds a Master’s degree in Biotechnological Law and Ethics from the University of Sheffield which preceded her MBA from the University of Liverpool, in the UK.
